Alector, Inc.
ALECNasdaqCIK 1653087HealthcareFiscal year ends Dec 31
Reports and events: 138 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1616:47 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-424204 |
| 2026-10-1409:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-421080 |
| 2026-10-0507:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-413090 |
| 2026-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338052 |
| 2026-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338008 |
| 2026-07-0816:05 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-298526 |
| 2026-06-1716:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-274130 |
| 2026-05-0717:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-212426 |
| 2026-05-0716:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211981 |
| 2026-05-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211918 |
| 2026-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2026-04-21 | 0001193125-26-186928 |
| 2026-02-2516:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071593 |
| 2026-02-2516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071557 |
| 2025-12-1216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-317554 |
| 2025-11-0616:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269592 |
| 2025-11-0616:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269537 |
| 2025-10-2116:08 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-245102 |
| 2025-08-0716:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105050 |
| 2025-08-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105023 |
| 2025-06-1316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-140731 |
| 2025-05-0816:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066987 |
| 2025-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066945 |
| 2025-04-2416:01 ET | DEF 14A | Proxy statementPeriod 2025-04-22 | 0000950170-25-057991 |
| 2025-03-2816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-046756 |
| 2025-03-1009:01 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-25-050448 |
| 2025-02-2616:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027758 |
| 2025-02-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027734 |
| 2025-01-1008:00 ET | 8-K | 8.01 Other events | 0000950170-25-003811 |
| 2024-11-2516:10 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-130564 |
| 2024-11-1416:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-127056 |
| 2024-11-0616:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122328 |
| 2024-11-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122296 |
| 2024-08-0716:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092814 |
| 2024-08-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092779 |
| 2024-06-1216:45 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-072512 |
| 2024-05-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055682 |
| 2024-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055652 |
| 2024-04-2516:01 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0000950170-24-048264 |
| 2024-03-2116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-073821 |
| 2024-02-2716:19 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021183 |
| 2024-02-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021133 |
| 2024-01-1906:09 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-010647 |
| 2024-01-1616:04 ET | 8-K | 2.02 Results of operations | 0001193125-24-008551 |
| 2023-11-0717:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-272546 |
| 2023-11-0716:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060270 |
| 2023-11-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060244 |
| 2023-08-0316:17 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-038023 |
| 2023-08-0316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-037982 |
| 2023-06-1516:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-167891 |
| 2023-05-0416:16 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017874 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:19 ET. Listed shows no prices and gives no investment advice.